Nanopartículas de CuO y su propiedad antimicrobiana en cepas intrahospitalarias

Empleando un prototipo de reactor, se sintetizaron nanopartículas (NPs) de CuO a través del método de precipitación a partir de CuSO2·5H2O y de Cu(CH3COO)2·H2O. Las NPs obtenidas fueron caracterizadas mediante XRD, FT-IR, TEM y SEM. La actividad antimicrobiana de las NPs se determinó mediante el método de difusión en placa, colocando 20 mg de NPs de CuO sobre cuatro cepas intrahospitalarias o nosocomiales aisladas de la Unidad de Cuidados Intensivos de un hospital nacional de Lima norte (Staphylococcus epidermidis, Aerococcus viridans, Ochrobactrum anthropi y Micrococcus lylae). La caracterización de las NPs de CuO demostró que las sintetizadas a partir de acetato (CuO–Acet) presentaron una fase pura de CuO, mientras que las sintetizadas a partir de sulfato (CuO–Sulf) presentaron dos fases, donde la de CuO representó más del 84%. Los dominios cristalinos del CuO–Acet y CuO–Sulf fueron 15 y 19 nm, respectivamente. Los halos de inhibición de las cepas estudiadas fueron mayores para las NPs de CuO–Sulf que para las NPs de CuO–Acet; solo para la cepa chrobactrum anthropi se presentaron halos similares para ambos tipos de NPs.Using a prototype reactor, CuO nanoparticles (NPs) were synthetized through the precipitation method, starting from CuSO2·5H2O and Cu(CH3COO)2·H2O. The obtained NPs were characterized by XDR, FT-IR, SEM, and TEM. The antimicrobial activity of the NPs was determined by the plate diffusion method, placing 20 mg of NPs onto four nosocomial strains obtained from north Lima national hospital Intensive-Care Unit (Staphylococcus epidermidis, Aerococcus viridans, Ochrobactrum anthropic, and Micrococcus lylae). NPs characterization revealed that those synthetized from acetate (CuO–Acet) shown pure CuO phase, while those synthetized from sulphate CuO–Sulf shown two phases where CuO was the predominant one, having more than 84%. The crystal domains for CuO–Acet and CuO–Sulf were 15 and 19 nm, respectively. The inhibition halos for the studied strains were larger for CuO–Sulf NPs than CuO–Acet NPs, only Ochrobactrum anthropi displayed similar inhibition halos for both types of NPs

Educación ambiental en el territorio antioqueño

El libro nace de las Jornadas Subregionales de Educación Ambiental realizadas por el ClDEA, para el cuál, se determinó seguir una ruta de sistematización que tiene varios atajos, sendas, vías que, unidas, entrecruzadas generaran un libro que recoge la normativa educativa ambiental, los antecedentes del Comité, lo diseñado, lo aplicado y lo aprendido en estas jornadas, al igual que los retos y la proyección de la educación ambiental en el Departamento. Los atajos son entendidos como caminos que indican cercanía, que acortan distancias y dan herramientas para conocer el territorio. Son un camino que les permite a las comunidades y al Comité, acercarse a los actores y tomadores de decisiones en el territorio antioqueño para hacer relaciones, análisis y proyecciones de los procesos educativos ambientales desarrollados en cada subregión. Para el ejercicio de la sistematización, se tuvo en cuenta la indagación desde la lectura del contexto, los referentes conceptuales y de política pública para el análisis, la reflexión, la interlocución con las comunidades, lo cual permitió hacer una aproximación a una investigación exploratoria porque facilitó tener una visión general inicial y de carácter aproximado o de primer nivel de conocimiento, sobre la conceptualización y los procesos de educación ambiental en el territorio, conocer algunas experiencias, las temáticas desarrolladas, las principales problemáticas ambientales y educativo-ambientales que preocupan a las comunidades, las estrategias de gestión y los actores que intervienen en la educación ambiental en el Departamento

Green Synthesis of Magnetic Nanoparticles of Iron Oxide Using Aqueous Extracts of Lemon Peel Waste and Its Application in Anti-Corrosive Coatings

Lately, the development of green chemistry methods with high efficiency for metal nanoparticle synthesis has become a primary focus among researchers. The main goal is to find an eco-friendly technique for the production of nanoparticles. Ferro- and ferrimagnetic materials such as magnetite (Fe3O4) exhibit superparamagnetic behavior at a nanometric scale. Magnetic nanoparticles have been gaining increasing interest in nanoscience and nanotechnology. This interest is attributed to their physicochemical properties, particle size, and low toxicity. The present work aims to synthesize magnetite nanoparticles in a single step using extracts of green lemon Citrus Aurantifolia residues. The results produced nanoparticles of smaller size using a method that is friendlier to health and the environment, is more profitable, and can be applied in anticorrosive coatings. The green synthesis was carried out by a co-precipitation method under variable temperature conditions. The X-ray Diffraction (XRD) and Transmission Electron Microscopy (TEM) characterization showed that magnetite nanoparticles were successfully obtained with a very narrow particle size distribution between 3 and 10 nm. A composite was produced with the nanoparticles and graphene to be used as a surface coating on steel. In addition, the coating’s anticorrosive behavior was evaluated through electrochemical techniques. The surface coating obtained showed good anticorrosive properties and resistance to abrasion

CuO nanoparticles and their antimicrobial activity against nosocomial strains

Using a prototype reactor, CuO nanoparticles (NPs) were synthetized through the precipitation method, starting from CuSO2·5H2O and Cu(CH3COO)2·H2O. The obtained NPs were characterized by XDR, FT-IR, SEM, and TEM. The antimicrobial activity of the NPs was determined by the plate diffusion method, placing 20 mg of NPs onto four nosocomial strains obtained from north Lima national hospital Intensive-Care Unit (Staphylococcus epidermidis, Aerococcus viridans, Ochrobactrum anthropic, and Micrococcus lylae). NPs characterization revealed that those synthetized from acetate (CuO–Acet) shown pure CuO phase, while those synthetized from sulphate CuO–Sulf shown two phases where CuO was the predominant one, having more than 84%. The crystal domains for CuO–Acet and CuO–Sulf were 15 and 19 nm, respectively. The inhibition halos for the studied strains were larger for CuO–Sulf NPs than CuO–Acet NPs, only Ochrobactrum anthropi displayed similar inhibition halos for both types of NPs

Avances de la Investigación en Ingeniería

El texto está conformado por 31 capítulos, agrupados en 5 grandes áreas temáticas. En la primera parte se encuentran los trabajos relacionados con el tema de los Recursos Hidráulicos; en la segunda parte se tratan temas relacionados con la Planificación y Gestión del Territorio; la tercera parte está relacionada con el Manejo Integral de los Recursos Agua, Aire y Suelo; la cuarta parte incluye la Investigación Aplicada a la Ingeniería de Sistemas, y la última parte comprende la Investigación Aplicada a la Ingeniería Civil

I simposio Internacional sobre Investigación en la enseñanza de las ciencias

Edición 202

Risk of COVID-19 after natural infection or vaccinationResearch in context

Summary: Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health

Risk of COVID-19 after natural infection or vaccinationResearch in context

Background: While vaccines have established utility against COVID-19, phase 3 efficacy studies have generally not comprehensively evaluated protection provided by previous infection or hybrid immunity (previous infection plus vaccination). Individual patient data from US government-supported harmonized vaccine trials provide an unprecedented sample population to address this issue. We characterized the protective efficacy of previous SARS-CoV-2 infection and hybrid immunity against COVID-19 early in the pandemic over three-to six-month follow-up and compared with vaccine-associated protection. Methods: In this post-hoc cross-protocol analysis of the Moderna, AstraZeneca, Janssen, and Novavax COVID-19 vaccine clinical trials, we allocated participants into four groups based on previous-infection status at enrolment and treatment: no previous infection/placebo; previous infection/placebo; no previous infection/vaccine; and previous infection/vaccine. The main outcome was RT-PCR-confirmed COVID-19 >7–15 days (per original protocols) after final study injection. We calculated crude and adjusted efficacy measures. Findings: Previous infection/placebo participants had a 92% decreased risk of future COVID-19 compared to no previous infection/placebo participants (overall hazard ratio [HR] ratio: 0.08; 95% CI: 0.05–0.13). Among single-dose Janssen participants, hybrid immunity conferred greater protection than vaccine alone (HR: 0.03; 95% CI: 0.01–0.10). Too few infections were observed to draw statistical inferences comparing hybrid immunity to vaccine alone for other trials. Vaccination, previous infection, and hybrid immunity all provided near-complete protection against severe disease. Interpretation: Previous infection, any hybrid immunity, and two-dose vaccination all provided substantial protection against symptomatic and severe COVID-19 through the early Delta period. Thus, as a surrogate for natural infection, vaccination remains the safest approach to protection. Funding: National Institutes of Health

Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

Background: Geoeconomic variations in epidemiology, the practice of ventilation, and outcome in invasively ventilated intensive care unit (ICU) patients without acute respiratory distress syndrome (ARDS) remain unexplored. In this analysis we aim to address these gaps using individual patient data of four large observational studies. Methods: In this pooled analysis we harmonised individual patient data from the ERICC, LUNG SAFE, PRoVENT, and PRoVENT-iMiC prospective observational studies, which were conducted from June, 2011, to December, 2018, in 534 ICUs in 54 countries. We used the 2016 World Bank classification to define two geoeconomic regions: middle-income countries (MICs) and high-income countries (HICs). ARDS was defined according to the Berlin criteria. Descriptive statistics were used to compare patients in MICs versus HICs. The primary outcome was the use of low tidal volume ventilation (LTVV) for the first 3 days of mechanical ventilation. Secondary outcomes were key ventilation parameters (tidal volume size, positive end-expiratory pressure, fraction of inspired oxygen, peak pressure, plateau pressure, driving pressure, and respiratory rate), patient characteristics, the risk for and actual development of acute respiratory distress syndrome after the first day of ventilation, duration of ventilation, ICU length of stay, and ICU mortality. Findings: Of the 7608 patients included in the original studies, this analysis included 3852 patients without ARDS, of whom 2345 were from MICs and 1507 were from HICs. Patients in MICs were younger, shorter and with a slightly lower body-mass index, more often had diabetes and active cancer, but less often chronic obstructive pulmonary disease and heart failure than patients from HICs. Sequential organ failure assessment scores were similar in MICs and HICs. Use of LTVV in MICs and HICs was comparable (42·4% vs 44·2%; absolute difference -1·69 [-9·58 to 6·11] p=0·67; data available in 3174 [82%] of 3852 patients). The median applied positive end expiratory pressure was lower in MICs than in HICs (5 [IQR 5-8] vs 6 [5-8] cm H2O; p=0·0011). ICU mortality was higher in MICs than in HICs (30·5% vs 19·9%; p=0·0004; adjusted effect 16·41% [95% CI 9·52-23·52]; p<0·0001) and was inversely associated with gross domestic product (adjusted odds ratio for a US$10 000 increase per capita 0·80 [95% CI 0·75-0·86]; p<0·0001). Interpretation: Despite similar disease severity and ventilation management, ICU mortality in patients without ARDS is higher in MICs than in HICs, with a strong association with country-level economic status